These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26137533)

  • 1. CD8(+) T-cell Cytotoxic Capacity Associated with Human Immunodeficiency Virus-1 Control Can Be Mediated through Various Epitopes and Human Leukocyte Antigen Types.
    Migueles SA; Mendoza D; Zimmerman MG; Martins KM; Toulmin SA; Kelly EP; Peterson BA; Johnson SA; Galson E; Poropatich KO; Patamawenu A; Imamichi H; Ober A; Rehm CA; Jones S; Hallahan CW; Follmann DA; Connors M
    EBioMedicine; 2015 Jan; 2(1):46-58. PubMed ID: 26137533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expansion ability but not the quality of HIV-specific CD8(+) T cells is associated with protective human leucocyte antigen class I alleles in long-term non-progressors.
    López M; Peris A; Soriano V; Lozano S; Vicario JL; Rallón NI; Restrepo C; Benito JM
    Immunology; 2011 Nov; 134(3):305-13. PubMed ID: 21978000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacious early antiviral activity of HIV Gag- and Pol-specific HLA-B 2705-restricted CD8+ T cells.
    Payne RP; Kløverpris H; Sacha JB; Brumme Z; Brumme C; Buus S; Sims S; Hickling S; Riddell L; Chen F; Luzzi G; Edwards A; Phillips R; Prado JG; Goulder PJ
    J Virol; 2010 Oct; 84(20):10543-57. PubMed ID: 20686036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA B*5701-positive long-term nonprogressors/elite controllers are not distinguished from progressors by the clonal composition of HIV-specific CD8+ T cells.
    Mendoza D; Royce C; Ruff LE; Ambrozak DR; Quigley MF; Dang T; Venturi V; Price DA; Douek DC; Migueles SA; Connors M
    J Virol; 2012 Apr; 86(7):4014-8. PubMed ID: 22278241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences.
    Migueles SA; Laborico AC; Imamichi H; Shupert WL; Royce C; McLaughlin M; Ehler L; Metcalf J; Liu S; Hallahan CW; Connors M
    J Virol; 2003 Jun; 77(12):6889-98. PubMed ID: 12768008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers.
    Ferre AL; Lemongello D; Hunt PW; Morris MM; Garcia JC; Pollard RB; Yee HF; Martin JN; Deeks SG; Shacklett BL
    J Virol; 2010 Oct; 84(19):10354-65. PubMed ID: 20668079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and interleukin-2 responsiveness.
    Jagannathan P; Osborne CM; Royce C; Manion MM; Tilton JC; Li L; Fischer S; Hallahan CW; Metcalf JA; McLaughlin M; Pipeling M; McDyer JF; Manley TJ; Meier JL; Altman JD; Hertel L; Davey RT; Connors M; Migueles SA
    J Virol; 2009 Mar; 83(6):2728-42. PubMed ID: 19129459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Immunodominance Hierarchy of CD8
    Adland E; Hill M; Lavandier N; Csala A; Edwards A; Chen F; Radkowski M; Kowalska JD; Paraskevis D; Hatzakis A; Valenzuela-Ponce H; Pfafferott K; Williams I; Pellegrino P; Borrow P; Mori M; Rockstroh J; Prado JG; Mothe B; Dalmau J; Martinez-Picado J; Tudor-Williams G; Frater J; Stryhn A; Buus S; Teran GR; Mallal S; John M; Buchbinder S; Kirk G; Martin J; Michael N; Fellay J; Deeks S; Walker B; Avila-Rios S; Cole D; Brander C; Carrington M; Goulder P
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29167337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel immunodominant CD8+ T cell response restricted by a common HLA-C allele targets a conserved region of Gag HIV-1 clade CRF01_AE infected Thais.
    Buranapraditkun S; Hempel U; Pitakpolrat P; Allgaier RL; Thantivorasit P; Lorenzen SI; Sirivichayakul S; Hildebrand WH; Altfeld M; Brander C; Walker BD; Phanuphak P; Hansasuta P; Rowland-Jones SL; Allen TM; Ruxrungtham K
    PLoS One; 2011; 6(8):e23603. PubMed ID: 21887282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two Distinct Mechanisms Leading to Loss of Virological Control in the Rare Group of Antiretroviral Therapy-Naive, Transiently Aviremic Children Living with HIV.
    Vieira VA; Adland E; Grayson NE; Csala A; Richards F; Dacon C; Athavale R; Tsai MH; D'Souza R; Muenchhoff M; Bonsall D; Jooste P; Goulder PJR
    J Virol; 2022 Jan; 96(2):e0153521. PubMed ID: 34757843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No major differences in the functional profile of HIV Gag and Nef-specific CD8+ responses between long-term nonprogressors and typical progressors.
    López M; Soriano V; Lozano S; Ballesteros C; Cascajero A; Rodés B; De La Vega E; González-Lahoz J; Benito JM
    AIDS Res Hum Retroviruses; 2008 Sep; 24(9):1185-95. PubMed ID: 18729773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent survival of prevalent clonotypes within an immunodominant HIV gag-specific CD8+ T cell response.
    van Bockel DJ; Price DA; Munier ML; Venturi V; Asher TE; Ladell K; Greenaway HY; Zaunders J; Douek DC; Cooper DA; Davenport MP; Kelleher AD
    J Immunol; 2011 Jan; 186(1):359-71. PubMed ID: 21135165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunodominance of HIV-1 specific CD8+ T-cell responses is related to disease progression rate in vertically infected adolescents.
    Sharp ER; Willberg CB; Kuebler PJ; Abadi J; Fennelly GJ; Dobroszycki J; Wiznia AA; Rosenberg MG; Nixon DF
    PLoS One; 2011; 6(7):e21135. PubMed ID: 21818255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents.
    Bansal A; Yue L; Conway J; Yusim K; Tang J; Kappes J; Kaslow RA; Wilson CM; Goepfert PA
    AIDS; 2007 Nov; 21(18):2387-97. PubMed ID: 18025875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection.
    Yu XG; Addo MM; Rosenberg ES; Rodriguez WR; Lee PK; Fitzpatrick CA; Johnston MN; Strick D; Goulder PJ; Walker BD; Altfeld M
    J Virol; 2002 Sep; 76(17):8690-701. PubMed ID: 12163589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of 2 HIV-1 Gag immunodominant epitopes restricted by Asian HLA allele HLA-B*4801.
    Murakoshi H; Kitano M; Akahoshi T; Kawashima Y; Dohki S; Oka S; Takiguchi M
    Hum Immunol; 2009 Mar; 70(3):170-4. PubMed ID: 19167445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8
    Murakoshi H; Zou C; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
    Retrovirology; 2018 Jul; 15(1):46. PubMed ID: 29970102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-specific T-cell Responses and Generalized Activation in HIV-1 Infected Long-term Non-progressors and Progressors from South India.
    Swathirajan CR; Vignesh R; Waldrop G; Shanmugasundaram U; Nandagopal P; Solomon SS; Pradeep A; Saravanan S; Murugavel KG
    Curr HIV Res; 2018; 16(4):302-314. PubMed ID: 30543175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoescape of HIV-1 in Env-EL9 CD8 + T cell response restricted by HLA-B*14:02 in a Non progressor who lost twenty-seven years of HIV-1 control.
    Moyano A; Blanch-Lombarte O; Tarancon-Diez L; Pedreño-Lopez N; Arenas M; Alvaro T; Casado C; Olivares I; Vera M; Rodriguez C; Del Romero J; López-Galíndez C; Ruiz-Mateos E; Prado JG; Pernas M
    Retrovirology; 2022 Mar; 19(1):6. PubMed ID: 35346235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The link between CD8⁺ T-cell antigen-sensitivity and HIV-suppressive capacity depends on HLA restriction, target epitope and viral isolate.
    Lissina A; Fastenackels S; Inglesias MC; Ladell K; McLaren JE; Briceño O; Gostick E; Papagno L; Autran B; Sauce D; Price DA; Saez-Cirion A; Appay V
    AIDS; 2014 Feb; 28(4):477-86. PubMed ID: 24384691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.